Awarded
RMH - CAR-T Treatment
The Royal Marsden NHS Foundation Trust · NHS and health
In brief
The Royal Marsden NHS Foundation Trust has awarded medical supplies work.
The buyer says it is suitable for small and medium-sized businesses.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials.
Who won
| Winner | Value | Dates |
|---|---|---|
| Not stated | £380,000 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Transparency notice · UK5, notice 068116-2025
About the buyer
The Royal Marsden NHS Foundation TrustLast 12 months
Procurements
21Awards
18Suppliers it has used most for medical supplies
- Adaptive Biotechnologies Corporation1 contract
- ELITech UK Ltd1 contract
- Ge Healthcare Limited1 contract
- IDT1 contract
- Novartis Pharmaceuticals UK Limited1 contract
Similar open tenders
All open medical supplies tenders- £85mestimated
- £3.6mestimated
- £250kestimated
- Value not stated
- £700kestimated
From notice 068116-2025 on Find a Tender, first published 24 October 2025. We last checked for changes on 28 September 2026.